Chemokines and Chemokine Receptors as Therapeutic Targets in Inflammatory Bowel Disease; Pitfalls and Promise

Mostrar otras versiones (1)

The principal targets for anti-chemokine therapy in inflammatory bowel disease (IBD) have been the receptors CCR9 and CXCR3 and their respective ligands CCL25 and CXCL10. More recently CCR6 and its ligand CCL20 have also received attention, the expression of the latter in enterocytes being manipulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Trivedi, Palak J, Adams, David H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104621/
https://www.ncbi.nlm.nih.gov/pubmed/30137309
http://dx.doi.org/10.1093/ecco-jcc/jjx145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104621/
https://www.ncbi.nlm.nih.gov/pubmed/30137309
http://dx.doi.org/10.1093/ecco-jcc/jjx145

Ejemplares similares